Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2021-10-14 Capital/Financing Update
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical carries out a directed share issue of SEK 159 million. Ilija Batljan enters as new large shareholder
Capital/Financing Update Classification · 1% confidence The document is a press release announcing a 'directed share issue of SEK 159 million' where new shares are being issued to specific investors (Ilija Batljan/Health Runner AB and others). This action directly relates to the company's capital structure and fundraising activities. According to the definitions, 'Capital/Financing Update (Code: CAP)' covers 'Updates on company fundraising, financing activities, or capital structure changes.' Although it involves shares, it is a financing event rather than a general share issue/repurchase announcement (SHA/POS), as the primary focus is raising capital through a specific placement. The document is a direct announcement of the financing event, not a report about it, making CAP the most appropriate classification.
2021-10-14 English
Episurf Medical provides COVID-19 related trading update
Earnings Release Classification · 1% confidence The document is a short trading update (3,414 characters) providing preliminary financial highlights (EBT and cash position) for Q3 2021 and commentary on business performance amidst the COVID-19 pandemic. It is an initial announcement of financial results rather than a full quarterly report or a report publication announcement. Therefore, it fits the definition of an Earnings Release (ER). 9M 2021
2021-10-14 English
Episurf Medical ger covid-19 relaterad affärsuppdatering
Regulatory Filings Classification · 1% confidence The document is a press release from Episurf Medical providing a business update regarding the impact of COVID-19 on their operations and preliminary financial results for the third quarter of 2021. It highlights key performance indicators such as pre-tax results and liquidity, but it is not a full quarterly report (IR) or a formal earnings release (ER) in the standard sense of a structured financial filing. Given the nature of the update as a regulatory disclosure under the EU Market Abuse Regulation, it fits best as a general regulatory announcement.
2021-10-14 Swedish
Nytt patentbeviljande i Kina för Episurf Medical
Regulatory Filings Classification · 1% confidence The document is a short announcement in Swedish regarding a new patent grant in China for Episurf Medical. It details the patent subject matter and includes standard contact and 'About Us' sections. Crucially, the final paragraph states: "Denna information är sådan information som Episurf Medical AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is such information that Episurf Medical AB is obliged to disclose according to the EU Market Abuse Regulation). This indicates a mandatory regulatory disclosure. Since the content is a specific announcement (patent grant) that doesn't fit into the defined categories like 10-K, ER, or DIV, and it is a regulatory disclosure, the most appropriate classification is the general regulatory filing fallback category, RNS (Regulatory Filings). The document length is short, but it is the primary disclosure itself, not an announcement *about* a report.
2021-10-13 Swedish
Valberedningens ledamöter inför Episurf Medicals årsstämma 2022
Board/Management Information Classification · 1% confidence The document is titled 'Valberedningens ledamöter inför Episurf Medicals årsstämma 2022' (Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2022). It details the composition and appointment of the Nomination Committee, which is directly related to the preparation and governance surrounding the Annual General Meeting (AGM). While it is not the AGM presentation itself (AGM-R) or the proxy statement (DEF 14A/PSI), information regarding the nomination committee members is a key component of corporate governance leading up to the AGM. Given the specific definitions, this content most closely aligns with Governance Information (CGR), as it details the structure and members responsible for nominating directors and auditors for the upcoming AGM. It is not a management change (MANG), nor is it a general voting result (DVA). CGR is the best fit for governance structure announcements.
2021-10-04 Swedish
Members of the Nomination Committee for Episurf Medical’s Annual General Meeting in 2022
AGM Information Classification · 1% confidence The document explicitly discusses the 'Members of the Nomination Committee for Episurf Medical's Annual General Meeting in 2022'. It details the composition, appointment process, and contact information related to the committee responsible for nominating board members and potentially setting the agenda for the AGM. This content is directly related to the governance and preparatory materials for the Annual General Meeting, fitting the description of AGM Information.
2021-10-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.